Morphic Therapeutic

1 follower

‌

Morphic Therapeutic is leading the development of a new generation of oral integrin drugs, informed by decades of world-leading expertise and a unique integrin discovery platform.

Industries

Employees

51-200

Links


Org chart

Praveen Tipirneni
President & CEO
Collapse
Chris Erdman
Senior Vice President, Investor Relations & Corporate Communications
Joanne Gibbons
SVP, Regulatory & Quality
Hanh Nguyen
SVP, Technical Operations
Brihad Abhyankar
Vice President, Clinical Development
Mimi Chae
Director Clinical Operations
Joseph Morris
Senior Director Information Technology
Terry Moy
Director Of Screening Biology
Sun Ku Lee
Executive Director

Board & advisors

Shelia Violette
Scientific Advisor
Albert Robichaud
Scientific Advisor
Ulrich H. Von Andrian
Scientific Advisor
Yury V. Popov
Scientific Advisor
Silvio Danese
Clinical Advisor
Brian G. Feagan
Clinical Advisor
Bruce Sands
Clinical Advisor
Stefan Schreiber
Clinical Advisor